Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SARS-CoV-2 Rapid Antigen Screening Test Validation, Usability, and Demonstration Study

NCT06452056 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT06452056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06452056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SARS-CoV-2 Rapid Antigen Screening Test Validation, Usability, and Demonstration Study
Lead sponsor
Columbia University
Phase
Observational
Overall status
Completed
Start date
January 7, 2021
Completion date
December 30, 2022
Enrollment
337 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov2 infection